| MeSH term | MeSH ID | Detail |
|---|---|---|
| Spinal Cord Injuries | D013119 | 34 associated lipids |
| Thyroid Neoplasms | D013964 | 33 associated lipids |
| Ventricular Dysfunction, Left | D018487 | 33 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Obesity | D009765 | 29 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Romas E et al. | Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. | 2002 | Bone | pmid:11856640 |
| Theill LE et al. | RANK-L and RANK: T cells, bone loss, and mammalian evolution. | 2002 | Annu. Rev. Immunol. | pmid:11861618 |
| Roux S et al. | RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. | 2002 | Am. J. Clin. Pathol. | pmid:11863217 |
| Green EA et al. | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. | 2002 | Immunity | pmid:11869680 |
| Faucheux C et al. | Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. | 2002 | J. Bone Miner. Res. | pmid:11874237 |
| Kazama JJ et al. | Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. | 2002 | Am. J. Kidney Dis. | pmid:11877571 |
| Haas M et al. | Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. | 2002 | Am. J. Kidney Dis. | pmid:11877577 |
| Feige U | Osteoprotegerin. | 2001 | Ann. Rheum. Dis. | pmid:11890662 |
| Holen I et al. | Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells. | 2002 | Cancer Res. | pmid:11912131 |
| Mori H et al. | RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse. | 2002 | Histochem. Cell Biol. | pmid:11914926 |